Crescendo Bioscience(R) Secures $28 Million in Series D Financing
January 03, 2013 09:00 ET
|
Crescendo Bioscience
SOUTH SAN FRANCISCO, Calif., Jan. 3, 2013 (GLOBE NEWSWIRE) -- Crescendo Bioscience®, a molecular diagnostics company dedicated to developing and commercializing quantitative blood tests for...
Crescendo Bioscience to Present Data on the Use of Vectra(TM) DA in Assessing Response to Treatments at American College of Rheumatology/Associate Rheumatology Health Professional Annual Meeting
November 10, 2012 16:30 ET
|
Crescendo Bioscience
SOUTH SAN FRANCISCO, Calif., Nov. 10, 2012 (GLOBE NEWSWIRE) -- Crescendo Bioscience®, a molecular diagnostics company dedicated to developing and commercializing quantitative blood tests for...
Crescendo Bioscience(R) Names Industry Leader Oscar Segurado, M.D., Ph.D., Chief Medical Officer
June 13, 2012 10:00 ET
|
Crescendo Bioscience
SOUTH SAN FRANCISCO, Calif., June 13, 2012 (GLOBE NEWSWIRE) -- Crescendo Bioscience®, a molecular diagnostics company developing and commercializing quantitative, biology-based tests for...
Nidus Announces Crescendo Bioscience is First Corporate Sponsor
May 17, 2012 13:40 ET
|
Crescendo Bioscience
SPOKANE, Wash., May 17, 2012 (GLOBE NEWSWIRE) -- The Nidus Physician Network Care Organization, a national medical organization dedicated to building partnerships between community and academic...
Crescendo Bioscience(R) Secures $56 Million in Funding to Expand Development and Commercialization of Personalized Diagnostics for Inflammatory Diseases
September 08, 2011 16:15 ET
|
Crescendo Bioscience
SOUTH SAN FRANCISCO, Calif., Sept. 8, 2011 (GLOBE NEWSWIRE) -- Crescendo Bioscience, a molecular diagnostics company developing quantitative biomarker tests for rheumatoid arthritis (RA) and other...